Sucralfate recalls
The FDA has published 6 recalls involving Sucralfate since 2022. The latest was reported on 22 Oct 2025. Most were for manufacturing (cgmp) deviations. Amerisource Health Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls6since 2022
Last 12 months0reported
Class I117% of total
Ongoing3latest 22 Oct 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 17%Class II 5 83%Class III 0 0%
Why sucralfate is recalled
Companies
By year
Ongoing sucralfate recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Sucralfate Tablets recalled by Amerisource Health Services | Amerisource Health Services | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Sucralfate Tablets recalled by Amerisource Health Services | Amerisource Health Services | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Sucralfate Tablets recalled by Nostrum Laboratories | Nostrum Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
All sucralfate recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Sucralfate Tablets recalled by Amerisource Health Services | Amerisource Health Services | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Sucralfate Tablets recalled by Amerisource Health Services | Amerisource Health Services | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Sucralfate Tablets recalled by Nostrum Laboratories | Nostrum Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS I | Sucralfate Oral Suspension per PET bottle) recalled by VistaPharmSucralfate | VistaPharm | Other Bacterial Contamination | Nationwide |
| Drug | CLASS II | Sucralfate Oral Suspension per, For Oral Administration Only bottle) recalledSucralfate | VistaPharm | Potency & Assay | Nationwide |
| Drug | CLASS II | Sucralfate Oral Suspension recalled by DASH Pharmaceuticals | Dash Pharmaceuticals | Packaging Defects | Nationwide |
Should you stop taking Sucralfate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.